| scholarly article | Q13442814 |
| P2093 | author name string | For-Wey Lung | |
| Ting-Sheng Cheng | |||
| Yi-Lung Chen | |||
| P2860 | cites work | Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses | Q28363535 |
| Longitudinal data analysis for discrete and continuous outcomes | Q29547235 | ||
| The neuropathology of schizophrenia. A critical review of the data and their interpretation | Q30573678 | ||
| Neuroleptic-induced hyperprolactinemia | Q33586375 | ||
| Review of recent clinical studies with olanzapine | Q33598440 | ||
| Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. | Q35089415 | ||
| Gender differences in the prescribing of antipsychotic drugs | Q35851946 | ||
| The genetics of schizophrenia: a current, genetic-epidemiologic perspective | Q40821125 | ||
| Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients | Q43638445 | ||
| Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia | Q43963204 | ||
| Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia. | Q44132357 | ||
| Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials | Q44371252 | ||
| A study of serum prolactin levels in schizophrenia: comparison of males and females | Q44710588 | ||
| Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. | Q44742690 | ||
| Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine | Q46951970 | ||
| Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. | Q51900805 | ||
| Significance of positive and negative syndromes in chronic schizophrenia. | Q52260049 | ||
| Excess of High Activity Monoamine Oxidase A Gene Promoter Alleles in Female Patients with Panic Disorder | Q57655561 | ||
| Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder | Q77603293 | ||
| A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia | Q79847612 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 16-20 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Primary Care Companion to the Journal of Clinical Psychiatry | Q15751574 |
| P1476 | title | Prolactin levels in olanzapine treatment correlate with positive symptoms of schizophrenia: results from an open-label, flexible-dose study | |
| P478 | volume | 11 |
| Q90353605 | A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future |
| Q51123490 | No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment. |
| Q47768462 | Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment. |
| Q33619940 | The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. |
Search more.